Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Health Law; Nursing Homes; New York; New Jersey; Massachusetts; Elder Law; Disability Rights; healthcare reform; healthcare; health; hospital; law; policy; COVID-19; elderly; insurance (1)
- Hospital; for-profit hospital; non-profit; healt care; healthcare; health care system; Patient Protection and Affordable Care Act; Affordable Care Act; ACA; Obamacare; health equity; Medicaid; healthcare reform; insurance; health insurance; health; health law; charity care; law; policy; Patient Assistance Program; Big Pharma; Drugs; Perscriptions; Consumer Protection; Law; Policy; Anti-Kickback (1)
Articles 1 - 2 of 2
Full-Text Articles in Social Welfare Law
America’S Constant Crisis Of Care: The Case For Passing A National Direct Care Ratio For Nursing Homes, Marissa Espinoza
America’S Constant Crisis Of Care: The Case For Passing A National Direct Care Ratio For Nursing Homes, Marissa Espinoza
Journal of Law and Policy
For decades, the conditions in America’s nursing homes have been the subject of bombshell media reporting, governmental investigations, and public outrage. Longstanding issues—such as chronic staffing shortages and inadequate infection control measures—were laid bare as the COVID-19 pandemic tore through nursing homes, exposing society’s most vulnerable populations—the elderly and the sick—to appalling living conditions. Amid horrifying media reports documenting life inside nursing homes, and in response to mounting public outrage, legislators sprang into action. The most aggressive policy proposed was a direct care ratio, which caps the profits that nursing home owners can extract from facilities by mandating a minimum …
The Patient Assistance Problem, Daniel O’Brien Lichtenauer
The Patient Assistance Problem, Daniel O’Brien Lichtenauer
Journal of Law and Policy
Implemented in January 2006 as a voluntary enrollment supplement to standard Medicare plans, Medicare Part D coverage subsidizes the cost of prescription drugs for participants. However, significant gaps in coverage exist for those suffering from rare diseases that require costly drugs. Pharmaceutical companies seek to remove the powerful market force of patient price sensitivity by directly sponsoring or substantially funding “patient assistance programs” that help cover out-of-pocket costs. While pharmaceutical donors insist that their goal is strictly altruistic, the reality is that many of these programs offer a financial windfall for drug makers because they help funnel patients towards new …